Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Valion Bio (TIVC) Cost of Revenue (2021 - 2025)

Valion Bio has reported Cost of Revenue over the past 5 years, most recently at $291000.0 for Q3 2025.

  • For Q3 2025, Cost of Revenue rose 254.88% year-over-year to $291000.0; the TTM value through Sep 2025 reached $1.2 million, down 50.84%, while the annual FY2024 figure was $1.2 million, 44.14% down from the prior year.
  • Cost of Revenue for Q3 2025 was $291000.0 at Valion Bio, up from $32000.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $1.6 million in Q4 2023 and troughed at $20000.0 in Q1 2025.
  • A 5-year average of $390842.1 and a median of $358000.0 in 2022 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: surged 335.07% in 2023 and later crashed 96.04% in 2025.
  • Year by year, Cost of Revenue stood at $200000.0 in 2021, then skyrocketed by 82.5% to $365000.0 in 2022, then skyrocketed by 335.07% to $1.6 million in 2023, then tumbled by 47.86% to $828000.0 in 2024, then tumbled by 64.86% to $291000.0 in 2025.
  • Business Quant data shows Cost of Revenue for TIVC at $291000.0 in Q3 2025, $32000.0 in Q2 2025, and $20000.0 in Q1 2025.